Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. HOOD
7. QCOM
8. ACN
9. AZN
10. ROIV

Go back to Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.56 -0.03 (1.16%)
Previous Close $2.59    52 Week High $7.79 
Open $2.55    52 Week Low $4.32 
Day High $2.63    P/E N/A 
Day Low $2.55    EPS $-0.36 
Volume 192,901       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.56 -0.03 (1.16%)
Previous Close $2.59    52 Week High $7.79 
Open $2.55    52 Week Low $4.32 
Day High $2.63    P/E N/A 
Day Low $2.55    EPS $-0.36 
Volume 192,901